Parabilis Medicines, Inc.

Parabilis Medicines, Inc. financial statements

Parabilis Medicines, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 145.89MEODHD
Cash and equivalentsUSD 27.71MEODHD
Total debtUSD 58.7MEODHD

Parabilis Medicines, Inc. financials on 6ix · Parabilis Medicines, Inc. on 6ix